Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investment strategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.

Lux Capital

JAZZ Venture Partners is the leading venture capital firm focused on technologies that extend the boundaries of human performance. They invest in companies at the intersection of digital technology and neuroscience. They are interested in companies that leverage cutting-edge brain science to inform powerful technology platforms that are impacting the human experience, such as virtual and augmented reality, immersive video gaming, artificial intelligence, and closed-loop human-computer systems. Their portfolio companies are unlocking human potential in important markets: health, mind-body wellness, peak mental and physical performance, accelerated learning and training, sports, and entertainment.  The partners are proven investors, entrepreneurs, neuroscientists, and technologists. They have deep domain experience and unparalleled access to innovative companies, talent, and strategic resources. Their multidisciplinary backgrounds allow us to meaningfully support exceptional entrepreneurs and executives in building category-defining companies.

Jazz Venture Partners

At Outsized Ventures we partner with founders pushing the boundaries of science and technology to solve the world’s greatest challenges. Some call it deep tech, others frontier tech, tough tech, hard tech or high tech - for us, it is simply the future.

Outsized Ventures

KKCG is an investment and innovation group with expertise in lotteries and gaming, energy, technology, and real estate. Founded by entrepreneur, investor, and philanthropist Karel Komárek, KKCG employs over 16,000 people in 37 countries across its portfolio companies, with more than €10 billion in assets under management.    KKCG’s businesses include, amongst others, Allwyn, a multi-national lottery operator; MND Group, an international producer and supplier of traditional and renewable energy; ARICOMA, Avenga and Qinshift, providing comprehensive IT services and custom software development around the globe; and KKCG Real Estate Group.    With operations on several continents, KKCG businesses draw on capital, networks, and insights from across the group to enable profitable, sustainable growth for the long term.   KKCG is committed to supporting the communities where it operates, contributing to the societies it works within.

KKCG

Main Street Advisors provides equity, fixed income, investment planning, asset allocation strategies, investment management, environmental, social, client asset management, and governance services.

Main Street Advisors

Mahana Therapeutics

Mahana Therapeutics develops digital treatments for people living with chronic health conditions that are designed to provide physical and psychological support that will be clinically proven to help patients feel better.

Mahana Therapeutics develops prescription digital therapeutics for chronic diseases, leveraging cognitive-behavioral therapies. The company’s flagship product, Mahana IBS, was the first digital therapeutic to receive FDA clearance for the treatment of irritable bowel syndrome (IBS) in March 2022.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

HiDocTechnologies–Mahana Therapeutics: investment, 202403 acquisition €na of Cara Care by Mahana Therapeutics

Bayer

This partnership is to expand the availability of prescription digital therapeutics

<div>
 
 Mahana Therapeutics develops PDTs for chronic diseases, leveraging cognitive-behavioral therapies. The company&rsquo;s flagship product, Mahana IBS, is a three-month treatment program that is available via a mobile app. It offers educational programs, allows users to track their IBS symptoms such as bloating and abdominal pain, and helps them to make required changes in thoughts and behaviors.
 
 
 In 
 <a href="https://sp-edge.com/updates/27496">
 March 2024
 </a>
 , acquired German DTx startup HiDoc Technologies, known as Cara Care, for an undisclosed amount to expand its digital therapeutics to the European market.
 
 
 Key customers and partnerships
 
 
 In 
 <a href="https://sp-edge.com/updates/21261">
 August 2023
 </a>
 , the company entered a multi-million dollar distribution and marketing agreement with Bayer's consumer health division to market Mahana's portfolio of prescription digital therapeutics.&nbsp;
 
 
 Funding and financials
 
 
 In 
 <a href="https://www.businesswire.com/news/home/20210811005170/en/Mahana-Therapeutics-Secures-61-Million-Series-B-Financing-to-Support-Commercialization-and-Further-Development-of-Digital-Therapeutics">
 August 2021
 </a>
 , the company raised USD 61 million via a Series B funding round co-led by JAZZ Venture Partners and Gurnet Point Capital. The funds were allocated to support the commercial launch of Mahana IBS and the acceleration of development for other digital therapeutics addressing chronic health conditions. 
 
</div>

Mahana Therapeutics develops prescription digital therapeutics for chronic diseases, leveraging cognitive-behavioral therapies. The company’s flagship product, Mahana IBS, was the first digital therapeutic to receive FDA clearance for the treatment of irritable bowel syndrome (IBS) in March 2022.Mahana IBS is a three-month treatment program that is available via a mobile app. It offers educational programs, allows users to track their IBS symptoms such as bloating and abdominal pain, and helps them to make required changes in thoughts and behaviors. Further, the company offers a digital therapeutic solution for tinnitus as well.In <a href="https://sp-edge.com/updates/27496">March 2024</a>, acquired German DTx startup HiDoc Technologies, known as <a href="https://sp-edge.com/companies/514500">Cara Care</a>, for an undisclosed amount to expand its digital therapeutics to the European market.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/21261">August 2023</a>, the company entered a multi-million dollar distribution and marketing agreement with Bayer's consumer health division to market Mahana's portfolio of prescription digital therapeutics.Funding and financialsIn <a href="https://www.businesswire.com/news/home/20210811005170/en/Mahana-Therapeutics-Secures-61-Million-Series-B-Financing-to-Support-Commercialization-and-Further-Development-of-Digital-Therapeutics">August 2021</a>, the company raised USD 61 million via a Series B funding round co-led by JAZZ Venture Partners and Gurnet Point Capital. The funds were allocated to support the commercial launch of Mahana IBS and the acceleration of development for other digital therapeutics addressing chronic health conditions.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

<div>
 Digital Therapeutics (DTx) company Mahana Therapeutics has acquired German startup HiDoc Technologies, or Cara Care, to further their growth in the European market. The purchase price remains undisclosed.
 This acquisition is a strategic move for Mahana Therapeutics, aiming to speed up their expansion in Europe, starting with France and the UK. The merged company plans to provide digital management programs for chronic conditions in various sectors such as digestive, hearing, dermatology, and women’s health, utilizing an exclusive cognitive behavioral therapy platform. 
</div>

Mahana Therapeutics

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless